These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31053861)

  • 21. Anabolic effects of oxandrolone after severe burn.
    Hart DW; Wolf SE; Ramzy PI; Chinkes DL; Beauford RB; Ferrando AA; Wolfe RR; Herndon DN
    Ann Surg; 2001 Apr; 233(4):556-64. PubMed ID: 11303139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns.
    Demling RH; DeSanti L
    J Trauma; 1997 Jul; 43(1):47-51. PubMed ID: 9253907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human growth hormone for treating burns and donor sites.
    Breederveld RS; Tuinebreijer WE
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008990. PubMed ID: 23235668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychiatric effects of anabolic steroids after burn injuries.
    Morton R; Gleason O; Yates W
    Psychosomatics; 2000; 41(1):66-8. PubMed ID: 10665271
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment.
    Przkora R; Jeschke MG; Barrow RE; Suman OE; Meyer WJ; Finnerty CC; Sanford AP; Lee J; Chinkes DL; Mlcak RP; Herndon DN
    Ann Surg; 2005 Sep; 242(3):384-9, discussion 390-1. PubMed ID: 16135924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification.
    Agarwal S; Loder S; Brownley C; Cholok D; Mangiavini L; Li J; Breuler C; Sung HH; Li S; Ranganathan K; Peterson J; Tompkins R; Herndon D; Xiao W; Jumlongras D; Olsen BR; Davis TA; Mishina Y; Schipani E; Levi B
    Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E338-47. PubMed ID: 26721400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of oxandrolone induced hepatic transaminitis in patients with burn injury.
    Kiracofe B; Coffey R; Jones LM; Bailey JK; Thomas S; Porter K; Murphy CV
    Burns; 2019 Jun; 45(4):891-897. PubMed ID: 30545697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxandrolone induced lean mass gain during recovery from severe burns is maintained after discontinuation of the anabolic steroid.
    Demling RH; DeSanti L
    Burns; 2003 Dec; 29(8):793-7. PubMed ID: 14636753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxandrolone in pediatric patients with severe thermal burn injury.
    Miller JT; Btaiche IF
    Ann Pharmacother; 2008 Sep; 42(9):1310-5. PubMed ID: 18682543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the impact of oxandrolone on outcomes in burn injured patients.
    Dobbe L; Clapp C; Larumbe-Zabala E; Griswold J
    Burns; 2019 Jun; 45(4):841-848. PubMed ID: 30527646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long-term effect of oxandrolone on hepatic acute phase proteins in severely burned children.
    Thomas S; Wolf SE; Murphy KD; Chinkes DL; Herndon DN
    J Trauma; 2004 Jan; 56(1):37-44. PubMed ID: 14749563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxandrolone Coadministration Does Not Alter Plasma Propranolol Concentrations in Severely Burned Pediatric Patients.
    Guillory AN; Herndon DN; Silva MB; Andersen CR; Suman OE; Finnerty CC
    J Burn Care Res; 2017; 38(4):243-250. PubMed ID: 28240622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical and psychosocial outcomes among burn-injured people with heterotopic ossification: A burn model system study.
    Won P; Pickering TA; Schneider JC; Kowalske K; Ryan CM; Carrougher GJ; Stewart BT; Yenikomshian HA
    Burns; 2024 May; 50(4):957-965. PubMed ID: 38267289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early detection of burn induced heterotopic ossification using transcutaneous Raman spectroscopy.
    Peterson JR; Okagbare PI; De La Rosa S; Cilwa KE; Perosky JE; Eboda ON; Donneys A; Su GL; Buchman SR; Cederna PS; Wang SC; Kozloff KM; Morris MD; Levi B
    Bone; 2013 May; 54(1):28-34. PubMed ID: 23314070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of eidronate disodium in the prevention of heterotopic ossification in burn patients.
    Shafer DM; Bay C; Caruso DM; Foster KN
    Burns; 2008 May; 34(3):355-60. PubMed ID: 17869001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of long-term oxandrolone administration in severely burned children.
    Murphy KD; Thomas S; Mlcak RP; Chinkes DL; Klein GL; Herndon DN
    Surgery; 2004 Aug; 136(2):219-24. PubMed ID: 15300183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Administration of Oxandrolone Improves Lung Function in Pediatric Burned Patients.
    Sousse LE; Herndon DN; Mlcak RP; Lee JO; Andersen CR; Zovath AJ; Finnerty CC; Suman OE
    J Burn Care Res; 2016; 37(5):273-7. PubMed ID: 27171844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summaries for patients. Oxandrolone treatment for pressure ulcers.
    Ann Intern Med; 2013 May; 158(10):I-20. PubMed ID: 23833788
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns.
    Diaz EC; Herndon DN; Porter C; Sidossis LS; Suman OE; Børsheim E
    Burns; 2015 Jun; 41(4):649-57. PubMed ID: 25468473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxandrolone use in adult burn patients. Systematic review and meta-analysis.
    Real DS; Reis RP; Piccolo MS; Okamoto RH; Gragnani A; Ferreira LM
    Acta Cir Bras; 2014; 29 Suppl 3():68-76. PubMed ID: 25351160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.